Outcome of bone marrow transplantation in acquired and inherited anaemia in the Republic of Ireland

Irish Journal of Medical Science

Volumn 174, Issue 3, 2005, Pages 13-19

  Piccin, Andrea ^a   O'Marcaigh, A ^a   Smith, O ^b   O'Riordan, J ^a   Crowley, M ^a   Vandenberg, E ^a   Gardiner, N ^a   Mc Cann, S ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PENTAMIDINE; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; DISEASE SEVERITY; DOSE RESPONSE; FANCONI ANEMIA; FEMALE; GENETIC COMPLEMENTATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; MORTALITY; RETROSPECTIVE STUDY; SERUM SICKNESS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 27844553343     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03169141     Document Type: Article

References (33)

1. Camitta BM. Criteria for severe aplastic anaemia. Lancet 1988 Feb 6;1(8580):303-4.
2. Heimpel H. Epidemiology and etiology of aplastic anaemia. In: Schrezenmeier H. Bacigalupo A. Aplastic Anaemia, (1st edition) Cambridge: Cambridge University Press. 2000:97-116.
3. Nakao S. Role of T-lymphocytes in the pathophysiology of aplastic anemia. In: Schrezenmeier H. Bacigalupo A. Aplastic Anaemia, (1st edition) Cambridge: Cambridge University Press. 2000:41-57.
4. Schroeder TM. Genetically determined chromosome instability syndromes. Cytogenet Cell Genet. 1982;33 (1-2):119-32.
5. Auerbach AD. Fanconi anaemia diagnosis and the diepoxybutane (DEB) test. Experimental Haematology 1993; 21, 731-733 Blood. 1996 Jan 1;87(1):386-92.
6. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994 Sep 1;84(5):1650-5.
7. Alessandri AJ, Rogers PC, Wadsworth LD, Davis JH. Diamond-blackfan anemia and cyclosporine therapy revisited. J Pediatr Hematol Oncol 2000 Mar-Apr;22(2):176-9.
8. Splain J, Berman BW. Cyclosporin A treatment for Diamond-Blackfan anemia. Am J Hematol 1993 Apr;42(4):406-7.
9. Passweg JR, Socie G, Hinterberger W et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997 Jul 15;90(2):858-64.
10. Bacigalupo A, Brand R., Oneto R et al. Treatment of acquired severe aplastic anaemia: Bone Marrow Transplantation Compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience. Seminars in Hematology 2000 Jan, 37, (1), 69-80
11. Bacigalupo A. Third ESCT/AMGEN workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplant (RIC-HISCT), and panel consensus. Bone Marrow Transplant 2004, 33: 691-696
12. Gupta V, Ball SE, Sage D et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005 Mar;35(5):467-71.
13. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anaemia. Blood 1994 Aug; 84, (3): 941-949
14. Flowers ME, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992 Mar;9(3):167-73
15. Zanis-Neto, J, Ribeiro RC, Medeiros C et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant 1995 Feb;15(2):293-8.
16. Gluckman E, Devergie A, Schaison G et al. Bone marrow transplantation in Fanconi Anaemia. Br J Haematol 1980, 45, 557-64
17. Kohli-Kumar M, Morris C, De Laat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994 Sep 15;84(6):2050-4.
18. Browne PV, Lawler M, Humphries P, Mc Cann SR. Donor-cell Leukemia after bone marrow transplantation for severe aplastic anemia. New Engl J Med 1991,325:710-713
19. Marsh JC, Ball SE, Darbyshire P et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003 Dec;123(5):782-801.
20. Socie G, Gluckman E, Raynal B et al. Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood 1993 Oct 1; 82(7):2249-56
21. De la Fuente J, Reiss S, McCloy M et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2004 Jul;34(1):95
22. Deeg HJ, Socie G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996 Jan 1;87(1):386-92.
23. Schrezenmeier H, Bredeson C, Bruno B et al. Comparison of allogeneic bone marrow and peripheral stem cell transplantation for severe Aplastic anaemia: Collaborative study of the European Group for Blood and Marrow Transplantation (EBMT) and International Bone Marrow Transplantation Registry (IBMTR). [abstract]. Blood 2004; 102:#267
24. Doney K., Leisenring W, Storb R et al. Transplant Team (1997) Primary treatment of aquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Int Med 126:107-115.
25. Weiden PL, Storb R, Slichter S, Warren RP, Sale GE. Effect of six weekly transfusions on canine marrow grafts: tests for sensitisation and abrogation of sensitisation by procarbazine and antithymocyte serum. J Immunol 1976 Jul;117(1):143-50
26. Bean MA, Graham T, Appelbaum FR et al. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitisation to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. Transplantation 1994 Feb;57(3):423-6.
27. Storb R, Deeg HJ. Failure of allogeneic canine marrow grafts after total body irradiation: allogeneic "resistance" vs transfusion induced sensitisation. Transplantation 42, 571
28. Passweg J. HLA-identical sibling bone marrow transplantation to treat severe aplastic anaemia. In: Schrezenmeier H. Bacigalupo A. Aplastic Anaemia, (1st edition) Cambridge: CambridgeUniversity Press. 2000: 230-25
29. Guardiola P, Socie G, Li X et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004 Jan 1;103(1):73-77
30. Hows J, Veum Stone J, Camitta BM. In: Schrezenmeier H. Bacigalupo A. Aplastic Anaernia, (1st edition) Cambridge University Press 2000, pag 258-274
31. Niederwieser D, Pepe M, Storb R, Loughran TP Jr, Longton G. Related Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. Br J Haematol 1988 May;69(1):23-8.
32. Ljungman P, Deliliers GL, Platzbecker U et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001 Jan 15;97(2):388-92.
33. Ryan C. Nicholson S, O'Connell, et al. The Hematology Journal 2004, (5), 548-55